HANSOH PHARMA(03692.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 4.26 billion, YoY increase of 35.82%

NewTimeSpace News: August 26, 2026, HANSOH PHARMA(03692.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 8.3 billion, increased by 11.71% YoY; Net Profit stood at CNY 4.26 billion, YoY increase of 35.82%; Profit Attributable to Shareholders stood at CNY 4.26 billion, YoY increase of 35.82%; Basic Earnings Per Share (EPS) stood at CNY 0.7.

In terms of profitability, HANSOH PHARMA Gross Profit changed from CNY 6.77 billion in the same period last year to CNY 7.63 billion in the current period, increased by CNY 860.15 million; gross profit margin changed from 91.11% in the same period last year to 91.92% in the current period, increased by 0.81 percentage points; net profit changed from CNY 3.13 billion in the same period last year to CNY 4.26 billion in the current period, increased by CNY 1.12 billion; net profit margin changed from 42.17% in the same period last year to 51.28% in the current period, increased by 9.11 percentage points. 

In terms of earnings quality, HANSOH PHARMA Operating Profit changed from CNY 3.69 billion in the same period last year to CNY 5.01 billion in the current period, increased by CNY 1.32 billion; Operating Profit Margin changed from 49.61% in the same period last year to 60.32% in the current period, increased by 10.71 percentage points. 

In terms of R&D investment focus, HANSOH PHARMA R&D Expenses changed from CNY 1.44 billion in the same period last year to CNY 1.74 billion in the current period, increased by CNY 298.54 million; R&D to Total Revenue Ratio changed from 19.38% in the same period last year to 20.95% in the current period, increased by 1.57 percentage points. 

By the close of trading on August 26, 2026, HANSOH PHARMA(03692) saw a gain of 0.51% in its share price, closing at HKD 31.74. The full-day turnover stood at HKD 347.79 million, with the latest market capitalization at HKD 192.48 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.